|
|
||||||||
Clinical Observations |
1 Both authors: Department of Radiology, The Churchill Hospital, Old Road, Oxford, OX3 7LJ, United Kingdom.
OBJECTIVE. Our objective was to determine the MDCT appearance of gastrointestinal stromal tumors (GISTs) after treatment with imatinib mesylate.
CONCLUSION. Cystic changes within primary and metastatic GISTs seen on MDCT in patients after imatinib mesylate therapy are evidence of disease response. Calcification may also occur in lesions that respond to therapy.
Keywords: CT gastrointestinal imaging gastrointestinal stromal tumors imatinib mesylate oncologic imaging
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |